These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 25574915)
101. Estimating the budget impact of a Tuberculosis strategic purchasing pilot study in Medan, Indonesia (2018-2019). Saragih S; Hafidz F; Nugroho A; Hatt L; O'Connell M; Caroline A; Cashin C; Imran S; Farianti Y; Afflazier A; Pakasi T; Badriyah N Health Econ Rev; 2024 Jun; 14(1):44. PubMed ID: 38904689 [TBL] [Abstract][Full Text] [Related]
102. Decentralised ECG monitoring for drug-resistant TB patients in ambulatory settings. Mbenga M; Slyzkyi A; Mirtskhulava V; Pak S; Gebhard A; Utepkalieva G; Sagimbekova A; Adenov M; Ryskulov G IJTLD Open; 2024 Apr; 1(4):192-194. PubMed ID: 38988404 [No Abstract] [Full Text] [Related]
103. Over US$100 million pledged to improve cancer care across Africa. Adepoju P Lancet Oncol; 2024 Sep; 25(9):1119. PubMed ID: 39068944 [No Abstract] [Full Text] [Related]
104. Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multicenter, randomized controlled study in China. Tang S; Yao L; Hao X; Liu Y; Zeng L; Liu G; Li M; Li F; Wu M; Zhu Y; Sun H; Gu J; Wang X; Zhang Z Clin Infect Dis; 2015 May; 60(9):1361-7. PubMed ID: 25605283 [TBL] [Abstract][Full Text] [Related]
105. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Merker M; Blin C; Mona S; Duforet-Frebourg N; Lecher S; Willery E; Blum MG; Rüsch-Gerdes S; Mokrousov I; Aleksic E; Allix-Béguec C; Antierens A; Augustynowicz-Kopeć E; Ballif M; Barletta F; Beck HP; Barry CE; Bonnet M; Borroni E; Campos-Herrero I; Cirillo D; Cox H; Crowe S; Crudu V; Diel R; Drobniewski F; Fauville-Dufaux M; Gagneux S; Ghebremichael S; Hanekom M; Hoffner S; Jiao WW; Kalon S; Kohl TA; Kontsevaya I; Lillebæk T; Maeda S; Nikolayevskyy V; Rasmussen M; Rastogi N; Samper S; Sanchez-Padilla E; Savic B; Shamputa IC; Shen A; Sng LH; Stakenas P; Toit K; Varaine F; Vukovic D; Wahl C; Warren R; Supply P; Niemann S; Wirth T Nat Genet; 2015 Mar; 47(3):242-9. PubMed ID: 25599400 [TBL] [Abstract][Full Text] [Related]
106. Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa. Cox H; Ramma L; Wilkinson L; Azevedo V; Sinanovic E Trop Med Int Health; 2015 Oct; 20(10):1337-45. PubMed ID: 25975868 [TBL] [Abstract][Full Text] [Related]
107. Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients. Van Deun A; Aung KJ; Hossain A; de Rijk P; Gumusboga M; Rigouts L; de Jong BC Int J Tuberc Lung Dis; 2015 Feb; 19(2):185-90. PubMed ID: 25574917 [TBL] [Abstract][Full Text] [Related]
108. The economic burden of TB diagnosis and treatment in South Africa. Foster N; Vassall A; Cleary S; Cunnama L; Churchyard G; Sinanovic E Soc Sci Med; 2015 Apr; 130():42-50. PubMed ID: 25681713 [TBL] [Abstract][Full Text] [Related]
109. Resistance patterns among multidrug-resistant tuberculosis patients in greater metropolitan Mumbai: trends over time. Dalal A; Pawaskar A; Das M; Desai R; Prabhudesai P; Chhajed P; Rajan S; Reddy D; Babu S; Jayalakshmi TK; Saranchuk P; Rodrigues C; Isaakidis P PLoS One; 2015; 10(1):e0116798. PubMed ID: 25606853 [TBL] [Abstract][Full Text] [Related]
110. Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant mycobacterium tuberculosis isolates from China. Zhao LL; Sun Q; Liu HC; Wu XC; Xiao TY; Zhao XQ; Li GL; Jiang Y; Zeng CY; Wan KL Antimicrob Agents Chemother; 2015 Apr; 59(4):2045-50. PubMed ID: 25605360 [TBL] [Abstract][Full Text] [Related]
111. Genomic epidemiology of multidrug-resistant Mycobacterium tuberculosis during transcontinental spread. Coscolla M; Barry PM; Oeltmann JE; Koshinsky H; Shaw T; Cilnis M; Posey J; Rose J; Weber T; Fofanov VY; Gagneux S; Kato-Maeda M; Metcalfe JZ J Infect Dis; 2015 Jul; 212(2):302-10. PubMed ID: 25601940 [TBL] [Abstract][Full Text] [Related]
112. Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa. Ramma L; Cox H; Wilkinson L; Foster N; Cunnama L; Vassall A; Sinanovic E Int J Tuberc Lung Dis; 2015 Dec; 19(12):1513-9. PubMed ID: 26614194 [TBL] [Abstract][Full Text] [Related]
113. Tuberculosis prevention in South Africa. Knight GM; Dodd PJ; Grant AD; Fielding KL; Churchyard GJ; White RG PLoS One; 2015; 10(4):e0122514. PubMed ID: 25849558 [TBL] [Abstract][Full Text] [Related]
114. Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease. Philley JV; Wallace RJ; Benwill JL; Taskar V; Brown-Elliott BA; Thakkar F; Aksamit TR; Griffith DE Chest; 2015 Aug; 148(2):499-506. PubMed ID: 25675393 [TBL] [Abstract][Full Text] [Related]
115. Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality? Bastard M; Bonnet M; du Cros P; Khamraev AK; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Telnov A; Sanchez-Padilla E; Hewison C; Varaine F Am J Respir Crit Care Med; 2015 Feb; 191(3):355-8. PubMed ID: 25635495 [No Abstract] [Full Text] [Related]
116. Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia. Walls G; Bulifon S; Breysse S; Daneth T; Bonnet M; Hurtado N; Molfino L Glob Health Action; 2015; 8():25964. PubMed ID: 25623609 [TBL] [Abstract][Full Text] [Related]
117. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting. Mandalakas AM; Kirchner HL; Walzl G; Gie RP; Schaaf HS; Cotton MF; Grewal HM; Hesseling AC Am J Respir Crit Care Med; 2015 Apr; 191(7):820-30. PubMed ID: 25622087 [TBL] [Abstract][Full Text] [Related]
118. Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach. Chamie G; Wandera B; Marquez C; Kato-Maeda M; Kamya MR; Havlir DV; Charlebois ED Trop Med Int Health; 2015 Apr; 20(4):537-45. PubMed ID: 25583212 [TBL] [Abstract][Full Text] [Related]
119. Towards tuberculosis elimination: an action framework for low-incidence countries. Lönnroth K; Migliori GB; Abubakar I; D'Ambrosio L; de Vries G; Diel R; Douglas P; Falzon D; Gaudreau MA; Goletti D; González Ochoa ER; LoBue P; Matteelli A; Njoo H; Solovic I; Story A; Tayeb T; van der Werf MJ; Weil D; Zellweger JP; Abdel Aziz M; Al Lawati MR; Aliberti S; Arrazola de Oñate W; Barreira D; Bhatia V; Blasi F; Bloom A; Bruchfeld J; Castelli F; Centis R; Chemtob D; Cirillo DM; Colorado A; Dadu A; Dahle UR; De Paoli L; Dias HM; Duarte R; Fattorini L; Gaga M; Getahun H; Glaziou P; Goguadze L; Del Granado M; Haas W; Järvinen A; Kwon GY; Mosca D; Nahid P; Nishikiori N; Noguer I; O'Donnell J; Pace-Asciak A; Pompa MG; Popescu GG; Robalo Cordeiro C; Rønning K; Ruhwald M; Sculier JP; Simunović A; Smith-Palmer A; Sotgiu G; Sulis G; Torres-Duque CA; Umeki K; Uplekar M; van Weezenbeek C; Vasankari T; Vitillo RJ; Voniatis C; Wanlin M; Raviglione MC Eur Respir J; 2015 Apr; 45(4):928-52. PubMed ID: 25792630 [TBL] [Abstract][Full Text] [Related]
120. Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors. Chung-Delgado K; Guillen-Bravo S; Revilla-Montag A; Bernabe-Ortiz A PLoS One; 2015; 10(3):e0119332. PubMed ID: 25790076 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]